CN1188657A - 'Ganyankang' oral liquid-for treating hepatitis and preparation method - Google Patents
'Ganyankang' oral liquid-for treating hepatitis and preparation method Download PDFInfo
- Publication number
- CN1188657A CN1188657A CN97106832A CN97106832A CN1188657A CN 1188657 A CN1188657 A CN 1188657A CN 97106832 A CN97106832 A CN 97106832A CN 97106832 A CN97106832 A CN 97106832A CN 1188657 A CN1188657 A CN 1188657A
- Authority
- CN
- China
- Prior art keywords
- herba
- treatment
- hepatitis
- taking
- course
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A medicine in the form of oral liquid for curing different hepatitides is prepared through such steps as decocting artemisiae capillaris, bushy knotweed rhizome and isatis root in water to obtain concentrated liquid, and addition of biphenyldicarboxylate and another component "Ganlixin", and features short course of treatment, quick transfer from positive to negative, no toxic side effect and low cost.
Description
The present invention relates to the field of Chinese medicines, be specially adapted to make the normal a kind of Chinese herbal and crude drugs preparations of liver function recovery within a short period of time after taking with Chinese herbal and crude drugs preparations treatment acute hepatitis, chronic hepatitis, alcoholic hepatitis, toxic hepatitis, drug induced hepatitis.
Polytypes such as the hepatitis of having found in the world at present has first, second, third, fourth, defend.The medicine that is used for the treatment of hepatitis both at home and abroad is also a lot, Chinese medicine class, Western medicine class, Chinese and Western is arranged in conjunction with the medicine class, not following tens of kinds of kinds, and these medicines all have certain curative effect to treatment hepatitis.But following shortcoming is arranged also: the one, the course of treatment is long, and the medicine that has 1 month was 1 course of treatment; The medicine that has two months was a course of treatment; The medicine (as YIGAN SAN) that also has three months was a course of treatment; The 2nd, treatment is tired, and the medicine that has is with the method for intravenous drip medicinal liquid to be imported human body; The medicinal liquid that has then needs intramuscular injection, have an injection every day; Also have Chinese herbal medicine then to need decoct twice morning and afternoon every day, very inconvenient; The 3rd, the expense height, patient infuses in hospital, has an injection, the course of treatment is long, medical expense is high.
The objective of the invention is to: provide a kind of Chinese herbal medicine formula to be mixed with oral liquid, patient is as long as every day is oral on time, and hepatitis symptom the lighter took through a course of treatment (8 days), and it is normal that liver function just can be recovered.Serious symptom person also only needs 2-3 the course of treatment and gets final product rehabilitation.The medicine that overcomes present treatment hepatitis exists the length course of treatment, weak curative effect, defective that expense is high.
Technical scheme of the present invention is: with Chinese herbal medicine formula, be mixed with the oral liquid patients and take.
1, pharmaceutical formulation: Herba Artemisiae Scopariae 60g, polygoni cuspidati,radix 30g, PINGDIMU 30g, Herba Salviae Chinensis 30g, BIANDIXIANG 30g, Herba Centellae 30g, Poria 30g, Herba Sedi Linearis 30g, Rohdea japonica 30g, Radix Isatidis 30g, Herba Hyperici Japonici 30g, Fructus Schisandrae Chinensis 20g, Radix Glycyrrhizae 20g, fry in shallow oil juice and add diammonium glycyrrhizinate 600mg, bifendate 67.5mg and make the daily dose medicinal liquid.
2, formulation preparation method: with Herba Artemisiae Scopariae 60g, polygoni cuspidati,radix 30g, PINGDIMU 30g, Herba Salviae Chinensis 30g, BIANDIXIANG 30g, Herba Centellae 30g, Poria 30g, Herba Sedi Linearis 30g, Rohdea japonica 30g, Radix Isatidis 30g, Herba Hyperici Japonici 30g, Fructus Schisandrae Chinensis 20g, Radix Glycyrrhizae 20g, clean, add 500 milliliters in water, place clay vessel to decoct, behind remaining 60ml dope, adding diammonium glycyrrhizinate 600mg, bifendate 67.5mg is daily dose, makes dosage 480ml bottling sealing in 8 days with method, be one the course of treatment oral liquid.
3, instructions of taking: 1 oral 20ml of hepatitis, day clothes three times, every day is early, middle and late respectively obeys 1 time, and 8 days is a course of treatment.
Curative effect exemplifies:
Patient Zhang Jinhua, the man, 23 years old, two double " great three positives " were found in health check-up in 94 years, later on liver function AST, ALT are unusual repeatedly, about 100n/l, use many Chinese medicines, Western medicine, but it is slower to fall enzyme, through with 20 milliliters of 1 clothes of quick-acting hepatitis health, obey every day three times, serve on 8 days, liver function recovery is normal.
Shu Jinzhong, man, 40 years old, Tang Gou people from town, Huaiyin City Guannan County.Suffer from hepatitis B 5 years, and checked liver function AST710n/L, ALT926n/L in May, 95.Through with course of treatment of quick-acting hepatitis health, the check liver function is significantly better, obeys a course of treatment again, and the liver function check recovers normal, and hepatitis symptom all disappears.
Hua Minfu, man, 42 years old, the worker of three-tree township, Zhunyin county supply and marketing cooperative, suffer from hepatitis B 8 years surplus, look into liver function AST1400N/L, ALT1970N/L in July, 95, because of financial difficulties, can not be in hospital, take three courses of treatment of quick-acting hepatitis health (24 days), liver function recovery is normal.
Zhu Xuejun, the man, 39 years old, Huaiyin City Qingpu District Yan He township flood was jumped gloomy peasant, suffer from hepatitis B 6 years surplus, yellowish urine is like strong tea water.Look into function AST1610N/L, ALT2100N/L, TB1L197.6 UMOL/L.Because of financial difficulties, can't hospitalization.Take quick-acting hepatitis health from April 21st, 96, check liver function and all take an evident turn for the better each course of treatment, and finish (32 days) the 4th course of treatment, and the check liver function recovery is normal.
This soup has following advantage and effect:
1, evident in efficacy: hepatitis is taken quick-acting hepatitis health, can be when short Between in make liver function recovery normal. Treated 356 routine hepatitis, efficient 100%, Cure rate 99.44%.
2, short treating period: hepatitis the lighter 1-2 course for the treatment of, general person 2-3 course for the treatment of, heavy Person 3-4 course for the treatment of, but medication period just rehabilitation in the longest month.
3, treatment is convenient: quick-acting hepatitis health are oral liquid medicines, each oral 20 milliliters (bite-size) do not need hepatitis to decoct liquid medicine, need not have an injection, hang the water treatment.
4, expense is cheap: because short treating period, cure fast. Therefore reduce dosage, subtract Few economic spending; The patient with severe symptoms only need be in and take, and does not need hospitalization, saves Institute's expense does not need to inject into a muscle, hang water. Can save a large amount of medical expense of patient.
Claims (1)
1, a kind of " quick-acting hepatitis health " prescription and preparation instructions of taking is characterized in that:
1. prescription is: Herba Artemisiae Scopariae 60g, polygoni cuspidati,radix 30g, PINGDIMU 30g, Herba Salviae Chinensis 30g, BIANDIXIANG 30g, Herba Centellae 30g, Poria 30g, Herba Sedi Linearis 30g, Rohdea japonica 30g, Radix Isatidis 30g, Herba Hyperici Japonici 30g, Fructus Schisandrae Chinensis 20g, Radix Glycyrrhizae 20g, fry in shallow oil juice and add diammonium glycyrrhizinate 600mg, bifendate 67.5mg and make the daily dose medicinal liquid.
2. compound method is: said herbal medicine is cleaned, added 500 milliliters in water, place clay vessel to decoct, behind remaining 60 milliliters of dopes, adding 600 milligrams of diammonium glycyrrhizinates, getting 67.5 milligrams of benzene dibasic acid esters is daily dose, makes dosage 480ml bottling in 8 days with method, sealing is a course of treatment.
3. instructions of taking is: oral 20ml every day three times, taking 8 continuously is a treatment cycle.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97106832A CN1067888C (en) | 1997-01-24 | 1997-01-24 | 'Ganyankang' oral liquid-for treating hepatitis and preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97106832A CN1067888C (en) | 1997-01-24 | 1997-01-24 | 'Ganyankang' oral liquid-for treating hepatitis and preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1188657A true CN1188657A (en) | 1998-07-29 |
| CN1067888C CN1067888C (en) | 2001-07-04 |
Family
ID=5169039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97106832A Expired - Fee Related CN1067888C (en) | 1997-01-24 | 1997-01-24 | 'Ganyankang' oral liquid-for treating hepatitis and preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1067888C (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100345585C (en) * | 2006-08-17 | 2007-10-31 | 汪敏 | Drug comprising biphenyldicarboxylate |
| CN100356962C (en) * | 2006-08-17 | 2007-12-26 | 张娜 | Traditional Chinese medicine and western medicine compositions comprising biphenyldicarboxylate |
| CN100363041C (en) * | 2006-08-17 | 2008-01-23 | 陈乃车 | Traditional Chinese medicine and western medicine cooperative compositions comprising biphenyldicarboxylate |
| CN100363040C (en) * | 2006-08-17 | 2008-01-23 | 张娜 | Medicinal compositions comprising biphenyldicarboxylate |
| CN100366283C (en) * | 2006-08-17 | 2008-02-06 | 齐鸽子 | Compositions comprising biphenyldicarboxylate |
| CN100366282C (en) * | 2006-08-17 | 2008-02-06 | 齐鸽子 | Medicinal compositions comprising biphenyldicarboxylate |
| CN100367980C (en) * | 2006-08-17 | 2008-02-13 | 陈乃车 | Cooperative compositions comprising biphenyldicarboxylate |
| CN100367986C (en) * | 2006-08-17 | 2008-02-13 | 陈乃车 | Cooperative drug comprising biphenyldicarboxylate |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1078897A (en) * | 1993-01-03 | 1993-12-01 | 于灵惠 | " hepatitis B health " Chinese medicine preparation and preparation technology thereof |
| CN1077384A (en) * | 1993-01-20 | 1993-10-20 | 吴传福 | The manufacture method of willow-dandelion tablet for preventing hepatitis |
-
1997
- 1997-01-24 CN CN97106832A patent/CN1067888C/en not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100345585C (en) * | 2006-08-17 | 2007-10-31 | 汪敏 | Drug comprising biphenyldicarboxylate |
| CN100356962C (en) * | 2006-08-17 | 2007-12-26 | 张娜 | Traditional Chinese medicine and western medicine compositions comprising biphenyldicarboxylate |
| CN100363041C (en) * | 2006-08-17 | 2008-01-23 | 陈乃车 | Traditional Chinese medicine and western medicine cooperative compositions comprising biphenyldicarboxylate |
| CN100363040C (en) * | 2006-08-17 | 2008-01-23 | 张娜 | Medicinal compositions comprising biphenyldicarboxylate |
| CN100366283C (en) * | 2006-08-17 | 2008-02-06 | 齐鸽子 | Compositions comprising biphenyldicarboxylate |
| CN100366282C (en) * | 2006-08-17 | 2008-02-06 | 齐鸽子 | Medicinal compositions comprising biphenyldicarboxylate |
| CN100367980C (en) * | 2006-08-17 | 2008-02-13 | 陈乃车 | Cooperative compositions comprising biphenyldicarboxylate |
| CN100367986C (en) * | 2006-08-17 | 2008-02-13 | 陈乃车 | Cooperative drug comprising biphenyldicarboxylate |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1067888C (en) | 2001-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102755594B (en) | Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof | |
| CN1057451C (en) | Children coryza medicine and preparing method | |
| CN100443112C (en) | Medicine for treating gout and gout arthritis | |
| CN1087625C (en) | Traditional Chinese medicine preparation for treating colitis | |
| CN1188657A (en) | 'Ganyankang' oral liquid-for treating hepatitis and preparation method | |
| CN1985921B (en) | Chinese medicine composition for treating common cold and its preparing method | |
| CN103977106B (en) | A kind of Chinese medicine preparation for the treatment of nephrotic syndrome and preparation method thereof | |
| CN102614324A (en) | Chinese medicinal synthetic preparation for assisting western medicines in treating phlebophlogosis | |
| CN1069058C (en) | Compound medicament for treating chronic pelvic inflammation | |
| CN101040650A (en) | Health-care type ganoderma lucidum combined tea | |
| CN1078905A (en) | A kind of medicine for external use for the treatment of hepatopathy | |
| CN1212147C (en) | Compound preparation of Chinese herbal medicine for treating chronic prostatitis and its preparing method | |
| CN1041277C (en) | Quick action injection | |
| CN1087945C (en) | Quick action traditional Chinese medicinal prepn. for giving-up drug | |
| CN106902330B (en) | Traditional Chinese medicine preparation for treating rheumatic arthritis and rheumatalgia and preparation method and application thereof | |
| CN1872330A (en) | Specific pellet for treating cold, and preparation method | |
| CN104645173A (en) | Drug for treatment or adjuvant treatment of AIDS (Acquired Immune Deficiency Syndrome), and preparation method and use method thereof | |
| CN1063074C (en) | Chinese herbs injection for treating oncoma (cancer) and preparation method | |
| CN104606578A (en) | Traditional Chinese medicine composition for treating superficial thrombophebitis caused by medicine | |
| CN1197599C (en) | Medicine for treating rheumatoid arthritis and tetanic rachitis | |
| CN1488372A (en) | Chinese medicine formual for treating heptitis | |
| CN102423440B (en) | Traditional Chinese drug effective fraction composition for treating cough, and preparation method thereof | |
| CN1092068C (en) | Hongchanjinu (liquid) soluble granules | |
| CN1119947A (en) | Prescription and preparation for hepatitis A | |
| CN101919943A (en) | The medicine of prevention or treatment cardiovascular and cerebrovascular disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |